Related Experiment Video
Updated: Apr 22, 2026
08:40
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
18.5K
Drug target miRNAs: chances and challenges.
1University Chemical Laboratory, University of Cambridge, Lensfield Road, CB2 1EW Cambridge, UK.
Trends in Biotechnology
|October 12, 2014
Summary
MicroRNAs (miRNAs) offer novel therapeutic strategies by regulating genes, targeting previously undruggable proteins for disease treatment. Developing miRNA-targeting drugs requires innovative approaches in drug discovery and development.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- MicroRNAs (miRNAs) are short RNA molecules that regulate gene expression.
- They offer a new avenue for targeting diseases by modulating gene regulation.
- Many proteins previously considered 'undruggable' can be targeted indirectly via miRNAs.
Purpose of the Study:
- To review the potential of miRNAs as drug targets.
- To highlight the challenges in developing miRNA-targeting drugs.
- To survey recent advances in miRNA drug discovery.
Main Methods:
- Literature review of scientific publications.
- Analysis of current trends in miRNA research.
- Survey of novel drug discovery approaches for miRNAs.
Main Results:
- miRNAs represent a promising class of drug targets.
- Significant challenges exist in developing effective miRNA-based therapeutics.
- New technologies and strategies are emerging to overcome these hurdles.
Conclusions:
- miRNA-targeting drugs hold potential for treating currently incurable diseases.
- Innovation in drug discovery is crucial for realizing this potential.
- This review serves as a guide for navigating the evolving field of miRNA therapeutics.
Related Concept Videos
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:22MicroRNAs
20.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.6K
01:22MicroRNAs
9.7K
9.7K
02:30siRNA - Small Interfering RNAs
13.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.3K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
02:15Experimental RNAi
6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K